VBI Vaccines, Inc. – (NASDAQ:VBIV)’s share price was up 5.5% during trading on Thursday . The company traded as high as $3.68 and last traded at $3.62, with a volume of 308,361 shares. The stock had previously closed at $3.43.

Separately, Ladenburg Thalmann started coverage on VBI Vaccines, Inc. – in a report on Tuesday, July 26th. They issued a “buy” rating on the stock.

The company’s market cap is $138.39 million. The company has a 50-day moving average price of $3.67 and a 200 day moving average price of $3.86.

VBI Vaccines Inc, formerly SciVac Therapeutics Inc, is a biotechnology company. The Company is engaged in developing various technologies that focus on vaccine protection. It has developed an enveloped virus like particle (eVLP) vaccine platform that allows for the design of enveloped VLP vaccines. It is involved in various projects related to human cytomegalovirus (CMV) and other antigens.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.